Newsfeeds Archive - Spark Newswire

2 minute read

FDA Approves X4 Pharmaceuticals’ Mavorixafor As First Therapy For Rare Immunodeficiency Disorder

April 29, 12:10 PM

FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare immunodeficiency disorder. Potential sales forecasted at $54.6M in 2024, rising to $450.9M by 2027.

XFOR

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

April 26, 12:31 PM

Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday’s regular session. The company’s market cap stands…

ACCD

4 minute read

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

December 11, 2:12 PM

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

AAGR

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

December 11, 1:30 PM

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 105.9% to $0.62 during Monday’s regular session. The company’s market cap…

BMEA

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

December 11, 9:06 AM

Gainers Pasithea Therapeutics (NASDAQ:KTTA) shares moved upwards by 86.6% to $0.56 during Monday’s pre-market session. The market value…

BMEA

2 minute read

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

December 11, 8:59 AM

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.

AAGR

22 minute read

Earnings

Earnings Scheduled For November 9, 2023

By Benzinga Insights

November 9, 7:52 AM

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

AAOI

1 minute read

Earnings

Earnings Outlook For X4 Pharmaceuticals

By Benzinga Insights

November 8, 1:01 PM

X4 Pharmaceuticals (NASDAQ:XFOR) is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here’s what investors…

XFOR

3 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

August 11, 1:31 PM

Gainers Tango Therapeutics (NASDAQ:TNGX) shares increased by 20.2% to $7.87 during Friday’s regular session. As of 13:31 EST,…

APLS

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

By Chris Katje

August 11, 10:54 AM

Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

DBTX